(3β,25S)-Spirost-5-en-3-yl O-6-deoxy-α-L-mannopyranosyl-(1→2)-O-[β-D-xylopyranosyl-(1→3)]-β-D-glucopyranoside

SKU HY-N0345-10 mg Category Tags ,

$250$400

Products Details

Product Description

– Liriope muscari baily saponins C is one of major active compounds of L. muscari (Decne.) Baily. Liriope muscari baily saponins C possesses strong anti-inflammatory, immunopharmacological and cardioprotective activities. Liriope muscari baily saponins C has been studied as a candidate agent for cancer metastasis[1].

Web ID

– HY-N0345

Storage Temperature

– -20°C (Powder, sealed storage, away from moisture and light)

Shipping

– Blue Ice

Applications

– COVID-19-immunoregulation

Molecular Formula

– C44H70O16

References

– [1]Ma S, et al. Safety evaluation of steroidal saponin DT-13 isolated from the tuber of Liriope muscari (Decne.) Baily. Food Chem Toxicol. 2011 Sep;49(9):2243-51.

CAS Number

– 87480-46-4

Molecular Weight

– 855.02

SMILES

– O[C@H]1[C@H](O)[C@@H](O)[C@@](O[C@@H]2[C@@H](O[C@@]3([H])[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)[C@@](O[C@@H]4CC5=CC[C@]([C@@](C[C@@]6([H])[C@]7([H])[C@H](C)[C@]8(OC[C@@H](C)CC8)O6)([H])[C@]7(C)CC9)([H])[C@@]9([H])[C@@]5(C)CC4)([H])O[C@H](CO)[C@H]2O)([H])OC1

Clinical Information

– No Development Reported

Research Area

– Cancer; Inflammation/Immunology

Solubility

– 10 mM in DMSO

Target

– Others

Pathway

– Others

Product type

– Natural Products

Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.

My Cart
Close Wishlist
Close Recently Viewed
Categories

Please fill out this form to request the file. We will send it to your Email address shortly. Thanks.

Please enable JavaScript in your browser to complete this form.

=

Please fill out this form to request the pricing.
We will send it to your email address shortly.
Thanks.

Please enable JavaScript in your browser to complete this form.

=